Related references
Note: Only part of the references are listed.Novel Role of Nuclear Receptor Rev-erbα in Hepatic Stellate Cell Activation: Potential Therapeutic Target for Liver Injury
Ting Li et al.
HEPATOLOGY (2014)
Novel Inflammatory Biomarkers of Portal Pressure in Compensated Cirrhosis Patients
Martina Buck et al.
HEPATOLOGY (2014)
Relaxin Modulates Human and Rat Hepatic Myofibroblast Function and Ameliorates Portal Hypertension In Vivo
Jonathan A. Fallowfield et al.
HEPATOLOGY (2014)
Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension
D. J. Leeming et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
CXCL12 induces hepatic stellate cell contraction through a calcium-independent pathway
Yedidya Saiman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Leptin receptor blockade reduces intrahepatic vascular resistance and portal pressure in an experimental model of rat liver cirrhosis
Maria Gabriela Delgado et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Prolactin in obese children: a bridge between inflammation and metabolic-endocrine dysfunction
Valeria Chirico et al.
CLINICAL ENDOCRINOLOGY (2013)
Thyroid dysfunction in thalassaemic patients: ferritin as a prognostic marker and combined iron chelators as an ideal therapy
Valeria Chirico et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
High-mobility group protein B1: a new biomarker of metabolic syndrome in obese children
Teresa Arrigo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Nasal High-Mobility Group Box-1 Protein in Children with Allergic Rhinitis
C. Salpietro et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2013)
Apelin is a marker of the progression of liver fibrosis and portal hypertension in patients with biliary atresia
Wei Chen et al.
PEDIATRIC SURGERY INTERNATIONAL (2013)
Soluble TNF-Alpha-Receptors I Are Prognostic Markers in TIPS-Treated Patients with Cirrhosis and Portal Hypertension
Jonel Trebicka et al.
PLOS ONE (2013)
Splanchnic-aortic inflammatory axis in experimental portal hypertension
Maria-Angeles Aller et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Antioxidant properties of glutamine and its role in VEGF-Akt pathways in portal hypertension gastropathy
Camila Marques et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
The Expression and Significance of CD4+CD25+CD127low/- Regulatory T cells and Foxp3 in Patients with Portal Hypertension and Hypersplenism
Yong Guo et al.
HEPATO-GASTROENTEROLOGY (2013)
Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis
H. Gronbaek et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension
Dong Wang et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2012)
High-frequency vagus nerve stimulation improves portal hypertension in cirrhotic rats
Ilse Bockx et al.
GUT (2012)
HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects
Sabine Klein et al.
JOURNAL OF HEPATOLOGY (2012)
Intestinal decontamination inhibits TLR4 dependent flbronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice
Qiang Zhu et al.
JOURNAL OF HEPATOLOGY (2012)
PPAR alpha activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats
Aina Rodriguez-Vilarrupla et al.
JOURNAL OF HEPATOLOGY (2012)
Oxidative stress and persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide and different oxygen concentrations
Eloisa Gitto et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2012)
Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture
Sven Francque et al.
LABORATORY INVESTIGATION (2012)
Management of portal hypertension in children
Roberto Gugig et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Hepatic fibrosis in paediatric liver disease
Imeke Goldschmidt et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2012)
Noninvasive Evaluation of Portal Hypertension: Emerging Tools and Techniques
V. K. Snowdon et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2012)
Therapeutic targets in liver fibrosis
Jonathan A. Fallowfield
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Gut-Brain Chemokine Changes in Portal Hypertensive Rats
Joaquin Merino et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats
Maria A. Cavasin et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2010)
Farglitazar Lacks Antifibrotic Activity in Patients With Chronic Hepatitis C Infection
John McHutchison et al.
GASTROENTEROLOGY (2010)
Treatment with the Leukotriene Inhibitor Montelukast for 10 Days Attenuates Portal Hypertension in Rat Liver Cirrhosis
Christian J. Steib et al.
HEPATOLOGY (2010)
Expression of NALP3 in the Spleen of Mice with Portal Hypertension
Zefeng Xia et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2010)
Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension
Mar Coll et al.
LIVER INTERNATIONAL (2010)
Pathology and pathogenesis of portal venopathy in idiopathic portal hypertension: Hints from systemic sclerosis
Yasuni Nakanuma et al.
HEPATOLOGY RESEARCH (2009)
Insulin Resistance Is Associated With Advanced Liver Fibrosis and High Body Mass Index in HIV/HCV-Coinfected Patients
Pablo Ryan et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Nodular regenerative hyperplasia: The main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities
Georgia Malamut et al.
JOURNAL OF HEPATOLOGY (2008)
Integrin αvβ6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies
Yury Popov et al.
JOURNAL OF HEPATOLOGY (2008)
Changes in count and function of spienic lymphocytes from patients with portal hypertension
Zong-Fang Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Role of cannabinoids in chronic liver diseases
Anna Parfieniuk et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats
Javier Munoz-Luque et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The role of lymphoid tissue inducer cells in splenic white pulp development
David R. Withers et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats
Mercedes Fernandez et al.
HEPATOLOGY (2007)
Autocrine VEGF signaling is required for vascular homeostasis
Sunyoung Lee et al.
CELL (2007)
Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients
Christoph Elsing et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Inflammation: a way to understanding the evolution of portal hypertension
Maria-Angeles Aller et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2007)
Prevention and management of Gastroesophageal varices and variceal hemorrhage in cirrhosis
Guadalupe Garcia-Tsao et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule
Y Iwakiri et al.
HEPATOLOGY (2006)
Plasma leptin, insulin, and neuropepticle Y response to feeding in newborn infants
C. Mami et al.
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2006)
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells
S Aleffi et al.
HEPATOLOGY (2005)
The third gas:: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis
S Fiorucci et al.
HEPATOLOGY (2005)
Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats:: Role of Akt signaling
KA Tazi et al.
GASTROENTEROLOGY (2005)
Tumor necrosis factor-α, interleukin-1β and nitric oxide:: Induction of liver megamitochondria in prehepatic portal hypertensive rats
I Prieto et al.
WORLD JOURNAL OF SURGERY (2005)
Inhibition of inhibitor of kappa B kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis
F Oakley et al.
GASTROENTEROLOGY (2005)
Endothelin-1 concentrations in cord blood of neonates with meconium-stained amniotic fluid
M Gemelli et al.
JOURNAL OF PERINATAL MEDICINE (2005)
Increased vascular heme oxygenase-1 expression contributes to arterial vasodilation in experimental cirrhosis in rats
YC Chen et al.
HEPATOLOGY (2004)
Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice - Implications for treatment of liver disease
NL Ward et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Intrasinusoidal cytotoxic CD8+T cells in nodular regenerative hyperplasia of the liver
M Ziol et al.
HUMAN PATHOLOGY (2004)
Liver development update: new embryo models, cell lineage control, and morphogenesis
F Lemaigre et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2004)
Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension
Y Iwakiri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension
D Rizzoni et al.
HYPERTENSION (2000)
Share Paper
